Vanessa Pietrowski Baldin

7PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Major global burdens of diseaseBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 22, 2025
Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis.

Vanessa Pietrowski Baldin, Christopher L Harding, Diana Quach

|Jul 09, 2025
Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis.

Vanessa Pietrowski Baldin, Christopher L Harding, Diana Quach

|Oct 03, 2024
Systematic review of tuberculous meningitis in high-risk populations: mortality and diagnostic disparities.

Andressa Lorena Ieque, Carolina Trevisolli Palomo, Deborah de Castro Moreira

|Feb 15, 2022
3,5-dinitrobenzoylhydrazone derivatives as a scaffold for antituberculosis drug development.

Tamires L Valverde, Eloísa G Sampiron, Débora C Montaholi

|Apr 29, 2021
In Vitro and In Silico Evaluations of Anti-Mycobacterium tuberculosis Activity of Benzohydrazones Compounds.

Eloísa Gibin Sampiron, Giovana Ferreira Costacurta, Leonora Lacerda Calsavara

|Nov 20, 2020
(-)-Camphene-based derivatives as potential antibacterial agents against Staphylococcus aureus and Enterococcus spp.

Beatriz C de Freitas, Paula A Queiroz, Vanessa P Baldin

Pageof 2